BMBL vs PTGX · rev $422.9M vs rev $269.8M
Bumble Inc (BMBL) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Bumble Inc (BMBL) is a internet content & information company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported BMBL revenue for 2026-06-30 was $422.9M. Net income was -$64.8M. Revenue was up 99.1% from 2026-03-31 to 2026-06-30. BMBL currently screens at market cap $974.7M.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
BMBL currently screens at market cap $974.7M. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the BMBL and PTGX stock pages for the full models.
Not investment advice.